Literature DB >> 19364823

Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling.

Scott A Robertson1, Rositsa I Koleva, Lawrence S Argetsinger, Christin Carter-Su, Jarrod A Marto, Edward P Feener, Martin G Myers.   

Abstract

Jak2, the cognate tyrosine kinase for numerous cytokine receptors, undergoes multisite phosphorylation during cytokine stimulation. To understand the role of phosphorylation in Jak2 regulation, we used mass spectrometry to identify numerous Jak2 phosphorylation sites and characterize their significance for Jak2 function. Two sites outside of the tyrosine kinase domain, Tyr(317) in the FERM domain and Tyr(637) in the JH2 domain, exhibited strong regulation of Jak2 activity. Mutation of Tyr(317) promotes increased Jak2 activity, and the phosphorylation of Tyr(317) during cytokine signaling requires prior activation loop phosphorylation, which is consistent with a role for Tyr(317) in the feedback inhibition of Jak2 kinase activity after receptor stimulation. Comparison to several previously identified regulatory phosphorylation sites on Jak2 revealed a dominant role for Tyr(317) in the attenuation of Jak2 signaling. In contrast, mutation of Tyr(637) decreased Jak2 signaling and activity and partially suppressed the activating JH2 V617F mutation, suggesting a role for Tyr(637) phosphorylation in the release of JH2 domain-mediated suppression of Jak2 kinase activity during cytokine stimulation. The phosphorylation of Tyr(317) and Tyr(637) act in concert with other regulatory events to maintain appropriate control of Jak2 activity and cytokine signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364823      PMCID: PMC2698725          DOI: 10.1128/MCB.00278-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.

Authors:  Pipsa Saharinen; Olli Silvennoinen
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

2.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

3.  Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.

Authors:  S J Frank; W Yi; Y Zhao; J F Goldsmith; G Gilliland; J Jiang; I Sakai; A S Kraft
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

4.  Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.

Authors:  Lawrence S Argetsinger; Jean-Louis K Kouadio; Hanno Steen; Allan Stensballe; Ole N Jensen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

5.  Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling.

Authors:  Edward P Feener; Felicia Rosario; Sarah L Dunn; Zlatina Stancheva; Martin G Myers
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

7.  Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.

Authors:  Jason H Kurzer; Lawrence S Argetsinger; Yong-Jie Zhou; Jean-Louis K Kouadio; John J O'Shea; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction.

Authors:  L Velazquez; K E Mogensen; G Barbieri; M Fellous; G Uzé; S Pellegrini
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

9.  The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain.

Authors:  Y Zhao; F Wagner; S J Frank; A S Kraft
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

Review 10.  Leptin receptor signaling and the regulation of mammalian physiology.

Authors:  Martin G Myers
Journal:  Recent Prog Horm Res       Date:  2004
View more
  16 in total

1.  p.Y317H is a new JAK2 gain-of-function mutation affecting the FERM domain in a myelofibrosis patient with CALR mutation.

Authors:  Laura Eder-Azanza; Cristina Hurtado; David Navarro-Herrera; Paula Aranaz; Francisco J Novo; José L Vizmanos
Journal:  Haematologica       Date:  2017-05-04       Impact factor: 9.941

2.  Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.

Authors:  Jacqueline Sayyah; Kavitha Gnanasambandan; Sushama Kamarajugadda; Shigeharu Tsuda; Jennifer Caldwell-Busby; Peter P Sayeski
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

Review 3.  A structure-function perspective of Jak2 mutations and implications for alternate drug design strategies: the road not taken.

Authors:  K Gnanasambandan; P P Sayeski
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

Review 5.  Obesity and leptin resistance: distinguishing cause from effect.

Authors:  Martin G Myers; Rudolph L Leibel; Randy J Seeley; Michael W Schwartz
Journal:  Trends Endocrinol Metab       Date:  2010-09-16       Impact factor: 12.015

6.  JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.

Authors:  Friederike Pastore; Aishwarya Krishnan; Henrik M Hammarén; Olli Silvennoinen; Benedict Yan; Ross L Levine
Journal:  Blood Adv       Date:  2020-09-22

7.  Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A.

Authors:  Alan Hammer; Leah Rider; Peter Oladimeji; Leslie Cook; Quanwen Li; Raymond R Mattingly; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2013-01-22

Review 8.  The molecular regulation of Janus kinase (JAK) activation.

Authors:  Jeffrey J Babon; Isabelle S Lucet; James M Murphy; Nicos A Nicola; Leila N Varghese
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

9.  Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.

Authors:  Dongqing Yan; Robert E Hutchison; Golam Mohi
Journal:  Blood       Date:  2012-07-26       Impact factor: 22.113

10.  Insufficiency of Janus kinase 2-autonomous leptin receptor signals for most physiologic leptin actions.

Authors:  Scott Robertson; Ryoko Ishida-Takahashi; Isao Tawara; Jiang Hu; Christa M Patterson; Justin C Jones; Rohit N Kulkarni; Martin G Myers
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.